Integrating Metabolic Engineering and Synthetic Biology for Next-generation Bio-manufacturing

Ulrich Thomsen^*
*Correspondence: Ulrich Thomsen, Department of Bioengineering, Karamanoğlu Mehmetbey University, Karaman, Turkey, Email:

Introduction

The convergence of metabolic engineering and synthetic biology represents a groundbreaking approach to bio-manufacturing, offering unprecedented opportunities for the sustainable production of chemicals, fuels, pharmaceuticals and other valuable products. Metabolic engineering, which involves the modification of cellular metabolic pathways to enhance the production of desired compounds, has long been a powerful tool in industrial biotechnology. Similarly, synthetic biology, with its focus on designing and constructing new biological systems or redesigning existing ones, takes bio-manufacturing to the next level by enabling the creation of entirely new pathways, organisms and bioprocesses. Together, these disciplines hold the potential to revolutionize the way we produce a wide range of products, moving us away from reliance on petrochemical-based processes and toward more sustainable, environmentally friendly methods. Metabolic engineering traditionally relies on the optimization of native biological pathways to enhance the production of specific metabolites or products, often in microorganisms like bacteria or yeast.

This approach has already proven successful in the large-scale production of biofuels, antibiotics and amino acids. However, as the demand for more complex, high-value products increases, traditional metabolic engineering approaches may not always be sufficient. This is where synthetic biology comes into play, enabling the design of entirely new metabolic pathways, the creation of engineered organisms with novel functionalities and the ability to rewire cellular processes to achieve more efficient and scalable production processes. The integration of metabolic engineering and synthetic biology has the potential to unlock a new era of bio-manufacturing, offering innovative solutions for a range of industries, from pharmaceuticals and agriculture to energy and materials science. By combining the strengths of both fields, researchers can design microorganisms or cell factories that are not only more efficient but also capable of producing complex compounds that were previously difficult or impossible to synthesize biologically. This integrated approach could lead to a future where sustainable, scalable and cost-effective bio-manufacturing becomes the norm, providing a wide range of benefits for industry, society and the environment [1].

Description

The integration of metabolic engineering and synthetic biology holds the potential to revolutionize bio-manufacturing by providing more sustainable, efficient and cost-effective methods for producing a wide range of valuable products. Metabolic engineering, which involves manipulating and optimizing the metabolic pathways of microorganisms to increase the production of specific compounds, has been a core tool in industrial biotechnology for decades. It has facilitated the large-scale production of products such as biofuels, antibiotics, amino acids and vitamins. However, the limitations of traditional metabolic engineering approaches become apparent when it comes to producing more complex compounds or improving efficiency at larger scales. This is where synthetic biology complements metabolic engineering by allowing for the design of entirely new biological systems and pathways, as well as the redesign of existing ones, to achieve desired outcomes. Synthetic biology goes beyond the optimization of natural metabolic pathways. It involves creating new biological parts, pathways and even entire synthetic organisms with the purpose of performing tasks that are not found in nature.

This discipline uses principles from engineering, biology and chemistry to design novel biological systems with the potential for higher efficiency, scalability and precision in bio-manufacturing processes. Through synthetic biology, researchers can engineer microorganisms to produce rare or difficult-to-synthesize molecules, such as complex pharmaceuticals, specialty chemicals and high-performance materials, which would otherwise be challenging to produce using traditional methods. By constructing new pathways or inserting synthetic circuits into microbial cells, synthetic biology can overcome the constraints of natural systems and optimize production. The combination of metabolic engineering and synthetic biology create a powerful synergy that enhances the capabilities of both fields. Metabolic engineering can be used to fine-tune existing pathways, ensuring high yields of desired products, while synthetic biology provides the tools to create novel pathways and new functionalities that push the boundaries of bio-manufacturing. This integration allows for the development of engineered microbial "factories" that can efficiently and sustainably produce a variety of products, ranging from biofuels and green chemicals to advanced materials and therapeutic proteins [2].

For example, in biofuel production, traditional metabolic engineering has been successfully applied to microorganisms like bacteria and yeast to improve their ability to ferment sugars into ethanol or other biofuels. However, the incorporation of synthetic biology tools could enable the creation of new, more efficient metabolic pathways that produce biofuels with higher energy content or from alternative feedstocks such as non-food biomass or even waste materials. Similarly, in the pharmaceutical industry, synthetic biology allows for the construction of entirely new biosynthetic pathways for the production of complex drugs, including antibiotics, vaccines and hormones that are difficult or costly to produce through conventional chemical synthesis or extraction from natural sources. Moreover, the integration of these two disciplines is not limited to just the production of chemicals and fuels. It also holds promise for biomanufacturing in agriculture, where engineered organisms could produce biobased pesticides, fertilizers, or even food additives that are more sustainable and environmentally friendly compared to their conventional counterparts.

In materials science, synthetic biology could enable the development of bio-based polymers and materials that are biodegradable, reducing reliance on petroleum-based plastics and minimizing environmental impact. The potential of metabolic engineering and synthetic biology for bio-manufacturing is not without challenges. One of the main hurdles is the complexity of designing and optimizing biological systems with precision. Biological systems are inherently more complex and variable than traditional industrial systems, making it difficult to predict and control their behavior in large-scale production. In addition, there are concerns about the ethical implications of genetic modifications, particularly when it comes to creating synthetic organisms that could potentially escape into the environment or be misused for harmful purposes. Furthermore, regulatory frameworks for synthetic biology and bio-manufacturing are still developing, which means that companies and researchers must navigate evolving guidelines and standards when deploying these technologies [3].

Despite these challenges, the integration of metabolic engineering and synthetic biology represents a promising future for bio-manufacturing. With continued advancements in genetic tools, computational biology and bioprocessing technologies, researchers are poised to create more efficient and scalable production processes that could dramatically reduce costs, improve sustainability and reduce dependence on fossil fuels. Moreover, as these fields continue to evolve, they have the potential to address some of the world’s most pressing challenges, including climate change, resource scarcity and public health. A key advantage of integrating synthetic biology with metabolic engineering is the ability to design entirely new pathways that address gaps or inefficiencies in natural systems. For instance, synthetic biology can be used to construct completely novel biochemical pathways that enable microorganisms to produce high-value compounds directly from alternative feedstocks, such as agricultural waste, industrial byproducts, or even carbon dioxide.

The direct conversion of carbon dioxide into biofuels or high-value chemicals, an approach known as carbon fixation, is an area where synthetic biology has the potential to make a substantial impact, reducing the reliance on petroleum-based resources and helping mitigate climate change. Additionally, synthetic biology provides tools for optimizing metabolic flux and enhancing the yield of products by introducing new regulatory circuits, feedback mechanisms, or even "genetic brakes" to control cellular metabolism. These precise interventions can address metabolic bottlenecks that limit the efficiency of production processes in traditional metabolic engineering. For example, in the production of bio-based chemicals or pharmaceuticals, synthetic biology can help ensure that the organism prioritizes the production of the desired compound by fine-tuning gene expression levels or optimizing enzyme kinetics [4].

Furthermore, synthetic biology enables the design of whole synthetic microbial communities, where different microorganisms are engineered to work together in a collaborative manner to produce a compound of interest. This concept of "synthetic consortia" can help overcome the challenges that arise when a single organism is insufficient to perform a multi-step biosynthesis or when a product is toxic to the producing microorganism. For example, one microorganism could be engineered to convert raw materials into an intermediate compound, while another organism in the consortium could be responsible for the final conversion of that intermediate into the desired product. Such systems may improve scalability and reduce production costs, as well as allow for the fine-tuning of various stages of production. The combination of metabolic engineering and synthetic biology also holds promise for the production of more sustainable materials. Researchers are exploring the use of engineered microorganisms to produce biodegradable plastics, such as Polyhydroxyalkanoates (PHAs), which could replace petroleum-derived plastics that contribute to environmental pollution. With synthetic biology, microorganisms can be engineered to produce plastics from renewable biomass or waste materials, offering a sustainable alternative to traditional plastic production. This has the potential to significantly reduce the environmental impact of plastic production and disposal [5].

Conclusion

In conclusion, combining metabolic engineering with synthetic biology opens the door to next-generation bio-manufacturing that can drive significant advancements in a wide variety of industries. This integrated approach provides the tools needed to design and optimize biological systems that produce valuable products more sustainably and efficiently. As research in both fields progresses, the potential to create novel compounds, reduce environmental impact and offer sustainable alternatives to traditional manufacturing processes becomes increasingly feasible, making this approach a key component of the future of industrial biotechnology.

Acknowledgment

None.

Conflict of Interest

None.

References

1. Marella, Eko Roy, Carina Holkenbrink, Verena Siewers and Irina Borodina. "Engineering microbial fatty acid metabolism for biofuels and biochemicals."Curr Opin Biotechnol50 (2018): 39-46.

   Google Scholar, Crossref, Indexed at

2. Liu, Junwei, Mara Novero, Tatsiana Charnikhova and Alessandra Ferrandino, et al. "Carotenoid cleavage dioxygenase 7 modulates plant growth, reproduction, senescence and determinate nodulation in the model legume Lotus japonicus."J Exp Bot 64 (2013): 1967-1981.

   Google Scholar, Crossref, Indexed at

3. Shi, Tian-Qiong, Farshad Darvishi, Mingfeng Cao and Boyang Ji, et al. "Design and construction of microbial cell factories for the production of fuels and chemicals."Front Bioeng Biotechnol 11 (2023): 1198317.

   Google Scholar, Crossref, Indexed at

4. Westfall, Patrick J., Douglas J. Pitera, Jacob R. Lenihan and Diana Eng, et al. "Production of amorphadiene in yeast and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin."Proc Natl Acad Sci 109 (2012): E111-E118.

   Google Scholar, Crossref, Indexed at

5. Capo, Alessandro, Antonino Natalello, Jan Marienhagen and Angela Pennacchio, et al. "Structural features of the glutamate-binding protein from Corynebacterium glutamicum." Int J Biol Macromol. 162 (2020): 903-912.

   Google Scholar, Crossref, Indexed at